Improving the Waiting List by Using 75-Year-Old Donors for Recipients With Hepatocellular Carcinoma

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 627-630

  Cascales Campos, P A ^a   Romero, P R ^a   Gonzalez, R ^a   Zambudio, A R ^a   Martinez Frutos, I M ^a   de la Pena J ^a   Bueno, F S ^a   Robles Campos, R ^a   Miras, M ^a   Pons Minano J A ^a   Sanmartin Monzo, A ^a   Domingo, J ^a   Bixquert Montagud, V ^a   Parrilla Paricio, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOSPORIN; METHYLPREDNISOLONE; PROTHROMBIN;

ABDOMINAL DRAINAGE; ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER GRAFT REJECTION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN DEATH; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE DONORS; WAITING LISTS;

EID: 77949460868     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.015     Document Type: Article

References (20)

1. Yao F.Y. Liver transplantation for hepatocelular carcinoma: beyond the milan criteria. Am J Transplant 8 (2008) 1982
2. Adam R., McMaster P., O'Grady J.G., et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. European Liver Transplant Association. Liver Transpl 9 (2003) 1231
3. Qiu J., Ozawa M., and Terasaki P.I. Liver transplantation in the United States. Clin Transpl (2005) 17
4. Gastaca M., Valdivieso A., Pijoan J., et al. Donors older than 70 years in liver transplantation. Transplant Proc 37 (2005) 3851
5. McCormack L., Petrowsky H., Jochum W., et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 246 (2007) 940
6. Munítiz V., Ramírez P., Robles R., et al. Sequential (domino) liver transplantation in familial amyloidotic polyneuropathy type II. Transplant Proc 34 (2002) 309
7. Abt P.L., Mange K.C., Olthoff K.M., et al. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4 (2004) 1302
8. Renz J.F., Yersiz H., Reichert P.R., et al. Split-liver transplantation: a review. Am J Transplant 3 (2003) 1323
9. Ríos A., Ramírez P., Robles R., et al. Split-liver transplant for two adults in a spanish hospital. Dig Dis Sci 52 (2007) 3240
10. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
11. Yi N.J., Suh K.S., Kim T., et al. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation. Oncology 75 suppl 1 (2008) 124
12. Sharma P., Balan V., Hernandez J.L., et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10 (2004) 36
13. Yao F.Y., Hirose R., LaBerge J.M., et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11 (2005) 1505
14. Yao F.Y., Kerlan Jr. R.K., Hirose R., et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 48 (2008) 819
15. Otto G., Herber S., Heise M., et al. M. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12 (2006) 1260
16. Pompili M., Mirante V.G., Rondinara G., et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 11 (2005) 1117
17. Sotiropoulos G.C., Paul A., Molmenti E., et al. Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants". Transplantation 80 (2005) 897
18. Zapletal C.H., Faust D., Wullstein C., et al. Does the liver ever age?. Results of liver transplantation with donors above 80 years of age. Transplant Proc 37 (2005) 1182
19. Anderson C.D., Vachharajani N., Doyle M., et al. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 207 (2008) 847
20. Condron S.L., Heneghan M.A., Patel K., et al. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 80 (2005) 145